Immune Characterization of Ibrutinib Therapy Following Allohct That Provides GVL Benefit without Gvhd Sahaf, B., Ryan, C. E., Rezvani, A., Nakasone, H., Otani, J., Coutre, S., Lowsky, R., Negrin, R., Miklos, D. B. ELSEVIER SCIENCE INC. 2016: S412

View details for DOI 10.1016/j.bbmt.2015.11.945

View details for Web of Science ID 000370910300620